Works about TELMISARTAN


Results: 183
    1
    2
    3
    4
    5

    Efficacy and Safety of Coadministered Ezetimibe–Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 6, p. 2377, doi. 10.3390/jcm12062377
    By:
    • Song, Zhao-Yan;
    • Kim, Moo-Hyun;
    • Lee, Han-Cheol;
    • Park, Sung-Ji;
    • Rhee, Moo-Yong;
    • Choi, Jong-Il;
    • Kim, Sang-Hyun;
    • Chae, In-Ho;
    • Hong, Young-Joon;
    • Lee, Nam-Ho;
    • Hwang, Gyo-Seung;
    • Hur, Seung-Ho;
    • Son, Jung-Woo;
    • Chae, Jei-Keon;
    • Kim, Hyo-Soo
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Antihypertensive drug telmisartan inhibits cell proliferation of gastrointestinal stromal tumor cells in vitro.

    Published in:
    Molecular Medicine Reports, 2020, v. 22, n. 2, p. 1063, doi. 10.3892/mmr.2020.11144
    By:
    • Kobara, Hideki;
    • Fujihara, Shintaro;
    • Iwama, Hisakazu;
    • Matsui, Takanori;
    • Fujimori, Ayako;
    • Chiyo, Taiga;
    • Tingting, Shi;
    • Kobayashi, Nobuya;
    • Nishiyama, Noriko;
    • Yachida, Tatsuo;
    • Tadokoro, Tomoko;
    • Oura, Kyoko;
    • Tani, Joji;
    • Fujita, Koji;
    • Nomura, Takako;
    • Yoneyama, Hirohito;
    • Morishita, Asahiro;
    • Okano, Keiichi;
    • Suzuki, Yasuyuki;
    • Mori, Hirohito
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Hipoglucemia en paciente sin diabetes.

    Published in:
    Revista Mexicana de Endocrinología, Metabolismo y Nutrición, 2021, v. 8, p. 6, doi. 10.24875/RME.M21000011
    By:
    • RAMÓN-GALLEGOS, ÁNGEL;
    • GARCÍA-CONTRERAS, ALDO I.;
    • AMADO-GALVÁN, MÓNICA;
    • RIVERA-MONTES, HÉCTOR;
    • ARIAS-RUIZ, CÉSAR;
    • VERGARA-LÓPEZ, ALMA
    Publication type:
    Article
    23

    Tradition Use Of Medication In Hypertension: A Survey Based Study.

    Published in:
    Journal of Namibian Studies, 2023, v. 38, p. 1777, doi. 10.1586/14779072.3.3.375.
    By:
    • Yousuf, Tanveer;
    • Alharbi, Abdullah Faleh;
    • Almajdi, Zaal Tarrah;
    • Alanazi, Aiyed Homoud;
    • Alanazi, Fahhad Hamoud;
    • Almotrafi, Yasser Mubrik;
    • Alsuhaimi, Saad Herab;
    • Almmutery, Ammar Naif;
    • Barak Almutairi, Abdulrazaq Thurayyan;
    • Awdh Alharbi, Yousef Owaidh;
    • Alboloi, Khalid Suliman;
    • Alharbi;
    • Shabbab, Mohammed;
    • Abdullah Alharbi, Abdulmaeen Abdulmatlob;
    • Abdullah Alshammari, Sultan Fraih;
    • Abdullah Alanazi, Ziyad Saleh
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Understanding the pH Dependence of Supersaturation State—A Case Study of Telmisartan.

    Published in:
    Pharmaceutics, 2022, v. 14, n. 8, p. 1635, doi. 10.3390/pharmaceutics14081635
    By:
    • Kádár, Szabina;
    • Csicsák, Dóra;
    • Tőzsér, Petra;
    • Farkas, Attila;
    • Pálla, Tamás;
    • Mirzahosseini, Arash;
    • Tóth, Blanka;
    • Tóth, Gergő;
    • Fiser, Béla;
    • Horváth, Péter;
    • Madarász, János;
    • Avdeef, Alex;
    • Takács-Novák, Krisztina;
    • Sinkó, Bálint;
    • Borbás, Enikő;
    • Völgyi, Gergely
    Publication type:
    Article
    35

    Combined Transcriptomic and Proteomic Profiling to Unravel Osimertinib, CARP-1 Functional Mimetic (CFM 4.17) Formulation and Telmisartan Combo Treatment in NSCLC Tumor Xenografts.

    Published in:
    Pharmaceutics, 2022, v. 14, n. 6, p. 1156, doi. 10.3390/pharmaceutics14061156
    By:
    • Nimma, Ramesh;
    • Kalvala, Anil Kumar;
    • Patel, Nilkumar;
    • Surapaneni, Sunil Kumar;
    • Sun, Li;
    • Singh, Rakesh;
    • Nottingham, Ebony;
    • Bagde, Arvind;
    • Kommineni, Nagavendra;
    • Arthur, Peggy;
    • Nathani, Aakash;
    • Meckes Jr., David G.;
    • Singh, Mandip
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Randomized, double-blinded, controlled clinical trial of the effect of captopril, telmisartan and their combination on systemic inflammation of patients on hemodialysis.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-22656-5
    By:
    • Ordaz-Medina, Susan M.;
    • Cueto-Manzano, Alfonso M.;
    • González-Plascencia, Juana;
    • Montañez-Fernández, José L.;
    • Ordaz-Medina, Elias J.;
    • Martín-del-Campo, Fabiola;
    • Cueto-Ramírez, Alfonso M.;
    • Martínez-Martínez, Petra;
    • Cortés-Sanabria, Laura;
    • Rojas-Campos, Enrique;
    • Trujillo-Hernández, Benjamín
    Publication type:
    Article